atugen AG demonstrates in vivo proof-of-concept in siRNA therapeutics

atugen AG, The Gene Silencing Company, announced today that it has demonstrated, in vivo, proof-of-concept in functional delivery of its highly stable siRNA therapeutics. In a series of repeat studies to test glucose tolerance in normal rodents, atugen’s siRNA therapy was shown to be effective in regulating blood sugar levels.

In the study, treatment with stabilized siRNA molecules (atuRNAi) through clinically-relevant i.v. infusion led to downregulation of a target which plays a significant role in regulating glucose metabolism in vivo. Compared to the control group, atuRNAi produced lower peak glucose levels with a return to near normal levels after two hours. In contrast, in animals treated with inactivated siRNA molecules, glucose levels rose to very high levels and failed to revert to normal within two hours.

The preclinical in vivo studies utilised a type II diabetes disease model in which an insulin-independent signalling pathway was turned on. Said Dr. Klaus Giese, “In this series of studies we have demonstrated robust and very reproducible tissue uptake and function of atugen’s proprietary siRNA therapeutic molecules. We are now moving on to animal studies in various cancer models.”

atugen’s patent application EP1389637 was published on 18 February 2004. The proprietary ‘composition of matter’ patent covers atugen’s own stabilized siRNA structures.

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Compact QKD system

… paves the way to cost-effective satellite-based quantum networks. Researchers demonstrate successful quantum key distribution between space lab and four ground stations. Researchers report an experimental demonstration of a space-to-ground…

Exploring quantum electron highways with laser light

Spiraling laser light reveals how topological insulators lose their ability to conduct electric current on their surfaces. Topological insulators, or TIs, have two faces: Electrons flow freely along their surface…

First image of antigen-bound T-cell receptor at atomic resolution

Immune system: Antigen binding does not trigger any structural changes in T-cell receptors – Signal transduction probably occurs after receptor enrichment. The immune system of vertebrates is a powerful weapon…

Partners & Sponsors